Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa
Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
BMJ Open. 2024 Nov 14;14(11):e082592. doi: 10.1136/bmjopen-2023-082592.
INTRODUCTION: Human papillomavirus (HPV) infection is the most prevalent sexually transmitted infection worldwide. HPV vaccination is an important tool to prevent and control HPV infection and its complications. Despite carrying the severe burden of disease, HPV vaccine coverage in Africa remains low. The aim of the current review is to evaluate the factors associated with HPV vaccination acceptance among adolescent men and women, young men and women, parents/caregivers, men who have sex with men, healthcare workers and programme managers in Africa. METHODS AND ANALYSIS: We will include peer-reviewed quantitative studies. We will search PubMed, Scopus, PsycInfo, Web of Science and Cochrane Central Register of Controlled Trials, with no language restriction, to identify eligible studies. Two review authors will independently screen the titles and abstracts of the search output in Covidence to select potentially eligible studies. The same two reviewers will independently screen the full-text of all identified potentially eligible articles to identify studies meeting inclusion criteria. Two review authors will independently extract data from eligible studies using a predefined data extraction form. Two review authors will independently assess the risk of bias in each included study, using the Effective Public Health Practice Project 'Quality Assessment Tool for Quantitative Studies'. We will assess the quality of evidence using the method for Grading of Recommendations Assessment, Development and Evaluation. ETHICS AND DISSEMINATION: Ethical approval is not required for this study because we will use already published data. The results of this review will be disseminated through peer-reviewed publication and conference presentation. PROSPERO REGISTRATION NUMBER: CRD42023475810.
简介:人乳头瘤病毒(HPV)感染是全球最普遍的性传播感染。HPV 疫苗接种是预防和控制 HPV 感染及其并发症的重要工具。尽管疾病负担严重,但非洲的 HPV 疫苗接种覆盖率仍然很低。本综述的目的是评估与非洲青少年男女、年轻男女、父母/照顾者、男男性行为者、卫生保健工作者和项目管理人员接受 HPV 疫苗接种相关的因素。
方法和分析:我们将纳入同行评议的定量研究。我们将在 PubMed、Scopus、PsycInfo、Web of Science 和 Cochrane 对照试验中心注册库中进行无语言限制的搜索,以确定合格的研究。两名综述作者将独立筛选 Covidence 中搜索结果的标题和摘要,以选择可能合格的研究。这两名相同的审查员将独立筛选所有确定的潜在合格文章的全文,以确定符合纳入标准的研究。两名综述作者将使用预先确定的数据提取表格,独立地从合格研究中提取数据。两名综述作者将使用有效公共卫生实践项目“定量研究质量评估工具”,独立评估每个纳入研究的偏倚风险。我们将使用推荐评估、制定和评估的方法来评估证据的质量。
伦理和传播:由于本研究将使用已发表的数据,因此不需要伦理批准。本综述的结果将通过同行评议的出版物和会议报告进行传播。
PROSPERO 注册号:CRD42023475810。
Cochrane Database Syst Rev. 2022-2-1
South Afr J HIV Med. 2018-5-23
JCO Glob Oncol. 2023-6
BMC Public Health. 2023-5-26